PRE-TREATMENT SERUM TESTOSTERONE LEVEL IS ASSOCIATED WITH ANDROGEN RESISTANCE IN PRIMARY LHRH-AGONIST THERAPY FOR PROSTATE CANCER

Authors :: Jeremy M Blumberg
Fang Niu
Pejvak Sassani
T. Craig Cheetham
Gary W. Chien
Stephen G. Williams
Steven J. Jacobsen
Source :: Journal of Urology. 181:98-98
Publication Year :: 2009
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2009.

Subjects :: PCA3
Oncology
Pre treatment
medicine.medical_specialty
LHRH Agonist
business.industry
medicine.drug_class
Urology
Cancer
medicine.disease
Androgen
Serum testosterone level
Prostate cancer
Internal medicine
Medicine
business

Tools